Indeed, FOXM1 overexpression was detected in a variety of human cancers and is associated with poor clinical prognosis42,43; it drives the expression of critical genes involved in the regulation of different cancer hallmarks including high proliferation, invasion, drug resistance, and angiogenesis. This evidence concerns the gene FOXM1 and cancer.